 |
Gancyclovir |
|---|---|
| Trade Name | |
| Orphan Indication | Severe human cytomegalovirus infections in specific immunosuppressed patient populations |
| USA Market Approval | USA |
| USA Designation Date | 1985-06-07 00:00:00 |
| Sponsor | Burroughs Wellcome Company;3030 Cornwallis Road, P.O. Box 12700;Research Triangle Park, North Carolina, 27709 |
